|
2. Etiologie
|
|
|
|
3.1 Tabac
|
|
|
|
Consumers unclear about risks or benefits of e-cigarettes [Reuters]
|
|
|
|
|
|
Researchers
in Scotland interviewed 64 smokers and found little consensus about the
potential benefits and harms of e-cigarettes, which may reflect
division in the medical community on the appropriateness of promoting
e-cigarettes as a safer alternative to the real thing.
|
|
|
|
|
|
|
5. Traitements
|
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.3 Traitements - FDA, EMA,...
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
Listening To The Voice Of The Patient In Precision Medicine [Forbes]
|
|
|
|
|
|
The
challenges of pulling together relevant patient information was also a
major theme. There were excruciating stories involving efforts to
extract data from electronic medical records (EMRs), and from multiple
EMRs – and the very high costs incurred when these efforts were
successful.
|
|
|
|
|
6.11 Patients
|
|
|
|
6.4 Médico-éco
|
|
|
|
|
6.6 Publications
|
|
|
No impact without data access [Nature Genetics]
|
|
|
|
|
|
A
considerable proportion of the usefulness and interest of research
publications in our field comes from the data and associated metadata.
We therefore insist that data be available for peer reviewers to see and
readers to use. Authors should use public permanent repositories
designed for appropriately consented data.
|
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|